Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Vera Therapeutics Inc Cl A
(NQ:
VERA
)
36.70
-0.95 (-2.52%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
368,006
Open
37.39
Bid (Size)
36.00 (1)
Ask (Size)
45.00 (1)
Prev. Close
37.65
Today's Range
36.40 - 37.66
52wk Range
9.240 - 50.78
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 09, 2024
From
Vera Therapeutics
Via
GlobeNewswire
VERA Stock Earnings: Vera Therapeutics Misses EPS for Q2 2024
August 08, 2024
VERA stock results show that Vera Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Performance
YTD
+135.11%
+135.11%
1 Month
+2.43%
+2.43%
3 Month
-1.13%
-1.13%
6 Month
-20.11%
-20.11%
1 Year
+95.32%
+95.32%
More News
Read More
Vera Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results
August 08, 2024
From
Vera Therapeutics
Via
GlobeNewswire
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 05, 2024
From
Vera Therapeutics
Via
GlobeNewswire
Vera Therapeutics: Q4 Earnings Insights
March 20, 2024
Via
Benzinga
Vera Therapeutics Announces Appointment of Industry Veteran David L. Johnson as Chief Operating Officer
July 01, 2024
From
Vera Therapeutics
Via
GlobeNewswire
Vera Therapeutics Appoints Christy J. Oliger to Board of Directors
June 11, 2024
From
Vera Therapeutics
Via
GlobeNewswire
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 07, 2024
From
Vera Therapeutics
Via
GlobeNewswire
Vera Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
June 07, 2024
From
Vera Therapeutics
Via
GlobeNewswire
Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
June 03, 2024
Via
Benzinga
Wall Street Snaps Five-Week Winning Streak, Economic Growth Slows, Inflation Holds Steady In April: This Week In The Market
May 31, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Nvidia Is Up 186% From A Year Ago, Yet These 7 Stocks Have More Than Doubled Their Returns Over The AI Chipmaker
May 29, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin A Nephropathy (IgAN)
May 28, 2024
From
Vera Therapeutics
Via
GlobeNewswire
Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b ORIGIN Study of Atacicept in IgAN at the 61st European Renal Association Congress
May 25, 2024
From
Vera Therapeutics
Via
GlobeNewswire
VERA Stock Earnings: Vera Therapeutics Misses EPS for Q1 2024
May 09, 2024
Via
InvestorPlace
Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
May 09, 2024
From
Vera Therapeutics
Via
GlobeNewswire
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 07, 2024
From
Vera Therapeutics
Via
GlobeNewswire
Could This Stock Be the Next Biotech Buyout?
April 13, 2024
Via
The Motley Fool
Vertex's Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept's Potential Impact
April 11, 2024
Via
Benzinga
Biotech Stocks Heat As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options
April 11, 2024
Via
Investor's Business Daily
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
April 11, 2024
Via
InvestorPlace
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
April 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 10, 2024
Via
Benzinga
Vera Therapeutics Announces Two Oral Presentations at the 61st European Renal Association Congress
April 02, 2024
From
Vera Therapeutics
Via
GlobeNewswire
VERA Stock Earnings: Vera Therapeutics Misses EPS for Q4 2023
March 20, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.